William Blair on MaxCyte Inc. (MXCT): CFO appointment 'not all that needle-moving' Mar 23, 2026 09:50AM
William Blair Downgrades MaxCyte Inc. (MXCT) to Market Perform Aug 7, 2025 04:02AM
MaxCyte to Participate in Upcoming Investor Conferences May 3, 2022 04:05PM
IPO for Cell-Engineering Firm MaxCyte (MXCT) Opens 31% Higher Jul 30, 2021 12:19PM
MaxCyte, Inc. (MXCT) Prices Upsized 13.5M Share Nasdaq IPO at $13/sh Jul 30, 2021 05:26AM


Jul 29, 2021 10:42PM MaxCyte Announces Pricing of Upsized Offering and Approval to List on the Nasdaq Global Select Market
Jul 26, 2021 07:50AM MaxCyte, Inc (MXCT) Announced 12M Share IPO at $11.50-$13.50
Jul 26, 2021 07:49AM MaxCyte Announces Launch of Offering and Application to List on the Nasdaq Global Market
Jul 12, 2021 05:20AM MaxCyte, Inc (MXCT) Files up to $100M IPO
Jul 12, 2021 02:00AM MaxCyte Announces Public Filing of Registration Statement with SEC for a Proposed Nasdaq Dual Listing